Citation APA
Perrot, A., Lauwers-Cances, V., Corre, J., Robillard, N., Hulin, C., Chretien, M.-L., Dejoie, T., Maheo, S., Stoppa, A. M., Pegourie, B., Karlin, L., Garderet, L., Arnulf, B., Doyen, C., Meuleman, N., Royer, B., Eveillard, J.-R., Benboubker, L., Dib, M., Decaux, O., Jaccard, A., Belhadj, K., Brechignac, S., Kolb, B., Fohrer, C., Mohty, M., Macro, M., Richardson, P. G., Carlton, V., Moorhead, M., Willis, T., Faham, M., Anderson, K. C., Harousseau, J.-L., Leleu, X., Facon, T., Moreau, P., Attal, M., Avet-Loiseau, H., & Munshi, N. (2018). Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma. Blood, 132(23), 2456-2464. doi:10.1182/blood-2018-06-858613
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/302985